These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9816762

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Implications of etiological research for preventive interventions and future research.
    Battjes RJ, Jones CL.
    NIDA Res Monogr; 1985; 56():269-76. PubMed ID: 3929104
    [No Abstract] [Full Text] [Related]

  • 6. Partying on? Life after BZP-based party pills.
    Green JA.
    N Z Med J; 2008 Oct 03; 121(1283):35-42. PubMed ID: 18841183
    [Abstract] [Full Text] [Related]

  • 7. The use of drugs within the techno party scene in European metropolitan cities.
    Tossmann P, Boldt S, Tensil MD.
    Eur Addict Res; 2001 Mar 03; 7(1):2-23. PubMed ID: 11316921
    [Abstract] [Full Text] [Related]

  • 8. Risk and benefit perceptions of party drug use.
    White B, Degenhardt L, Breen C, Bruno R, Newman J, Proudfoot P.
    Addict Behav; 2006 Jan 03; 31(1):137-42. PubMed ID: 15907371
    [Abstract] [Full Text] [Related]

  • 9. The role of peers in the initiation and continuation of ecstasy use.
    Vervaeke HK, van Deursen L, Korf DJ.
    Subst Use Misuse; 2008 Jan 03; 43(5):633-46. PubMed ID: 18393081
    [Abstract] [Full Text] [Related]

  • 10. Rave drugs: pharmacological considerations.
    Klein M, Kramer F.
    AANA J; 2004 Feb 03; 72(1):61-7. PubMed ID: 15098519
    [Abstract] [Full Text] [Related]

  • 11. Raves: a review of the culture, the drugs and the prevention of harm.
    Weir E.
    CMAJ; 2000 Jun 27; 162(13):1843-8. PubMed ID: 10906922
    [Abstract] [Full Text] [Related]

  • 12. Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006.
    Wilkins C, Sweetsur P.
    N Z Med J; 2008 May 23; 121(1274):61-71. PubMed ID: 18535647
    [Abstract] [Full Text] [Related]

  • 13. Young drug addicts and the drug scene.
    Lucchini R.
    Bull Narc; 1985 May 23; 37(2-3):135-48. PubMed ID: 4075000
    [Abstract] [Full Text] [Related]

  • 14. School-based substance use prevention programs: why do effects decay?
    Resnicow K, Botvin G.
    Prev Med; 1993 Jul 23; 22(4):484-90. PubMed ID: 8415498
    [No Abstract] [Full Text] [Related]

  • 15. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G, Bailly D, Boss V, Thomas P, Lestavel P, Goudemand M.
    Encephale; 2001 Jul 23; 27(2):198-202. PubMed ID: 11407274
    [Abstract] [Full Text] [Related]

  • 16. [Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
    Christensen HR.
    Ugeskr Laeger; 1999 Dec 13; 161(50):6899. PubMed ID: 10643372
    [No Abstract] [Full Text] [Related]

  • 17. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR, Cole JC, Jerome L.
    J Psychopharmacol; 2006 Sep 13; 20(5):670-82. PubMed ID: 16401654
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical and toxicological aspects of the use of ecstasy].
    Keppel Hesselink JM.
    Ned Tijdschr Geneeskd; 1998 Oct 17; 142(42):2321-2. PubMed ID: 9864530
    [No Abstract] [Full Text] [Related]

  • 20. Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
    Yen CF, Hsu SY, Cheng CP.
    Addict Behav; 2007 Oct 17; 32(10):2286-91. PubMed ID: 17314013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.